Abstract
A multidisciplinary iAssay telehealth research collaboration addresses Point of Care needs of underserved diabetes clients utilizing a wireless mobile handheld blood glucose- and cholesterol-testing iAssay System device. The device remotely monitors blood chemistries, rapid blood panel testing and diagnosis in non-clinical settings improving patient outcomes, at significantly decreased costs.
Sigma Membership
Unknown
Lead Author Affiliation
National University, Costa Mesa, California, USA
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Point of Care, Telemedicine Technology, Interprofessional Collaborative Practice
Recommended Citation
Humbles, Patricia L.; Parker, Ricardo; Yep, Kristen; Crews, Allysa; and Singh, Kendra, "Telehealth diabetes screening utility of a wireless handheld iAssay blood analyzer: A cost benefit analysis" (2019). INRC (Congress). 430.
https://www.sigmarepository.org/inrc/2019/posters_2019/430
Conference Name
30th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Calgary, Alberta, Canada
Conference Year
2019
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Telehealth diabetes screening utility of a wireless handheld iAssay blood analyzer: A cost benefit analysis
Calgary, Alberta, Canada
A multidisciplinary iAssay telehealth research collaboration addresses Point of Care needs of underserved diabetes clients utilizing a wireless mobile handheld blood glucose- and cholesterol-testing iAssay System device. The device remotely monitors blood chemistries, rapid blood panel testing and diagnosis in non-clinical settings improving patient outcomes, at significantly decreased costs.